Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus

Samankaltaisia teoksia

• Short- and Long-Term Clinical Outcomes in Rhesus Monkeys Inoculated with a Highly Pathogenic Chimeric Simian/Human Immunodeficiency Virus
  Tekijä: Endo, Yasuyuki, et al.
  Julkaistu: (2000)
• Early Control of Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys Usually Results in Long-Lasting Asymptomatic Clinical Outcomes
  Tekijä: Igarashi, Tatsuhiko, et al.
  Julkaistu: (2003)
• Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies
  Tekijä: Nishimura, Yoshiaki, et al.
  Julkaistu: (2002)
• Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4(+) T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
  Tekijä: Igarashi, Tatsuhiko, et al.
  Julkaistu: (2001)
• Induction of Disease by a Molecularly Cloned Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimera Is Multigenic
  Tekijä: Sadjadpour, Reza, et al.
  Julkaistu: (2004)